Upcoming Events
Thirteenth European International Kidney Cancer Symposium
April 27 - April 28Kidney Cancer Association 2018 Patient Meeting
September 22 - September 23Seventeenth International Kidney Cancer Symposium
November 2 - November 3
Publications
From the Pressroom
Videos: 2017 Kidney Cancer Association Patient & Survivor Conference
Videos from KCA patient and survivor conference that held in North Carolina on December 9th, 2017 is now available online.
FDA Grants Breakthrough Designation for Avelumab in Combination with INLYTA in Advanced Renal Cell Carcinoma
A combination approach with an immunotherapy, whose activity may complement existing agents such as INLYTA, has the potential to improve outcomes for patients with advanced renal cancer…
FDA Approves Adjuvant Sunitinib for High-Risk RCC
The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.
YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.
